pubmed-article:21149918 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0209738 | lld:lifeskim |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0663655 | lld:lifeskim |
pubmed-article:21149918 | lifeskim:mentions | umls-concept:C0814633 | lld:lifeskim |
pubmed-article:21149918 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:21149918 | pubmed:dateCreated | 2010-12-14 | lld:pubmed |
pubmed-article:21149918 | pubmed:abstractText | No data on once-daily dosing of nucleoside analogues in African children currently exist. We compared the pharmacokinetics (PK) of once- versus twice-daily lamivudine and abacavir treatment using the World Health Organization recommended weight band dosing of scored adult tablets. | lld:pubmed |
pubmed-article:21149918 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:language | eng | lld:pubmed |
pubmed-article:21149918 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21149918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21149918 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21149918 | pubmed:issn | 2040-2058 | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:MugyenyiPeter... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:GibbDiana MDM | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:MusokePhilipp... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:WalkerA... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:BurgerDavidD | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:Bakeera-Kitak... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:AdkisonKimber... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:KekitiinwaAde... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:MusiimeVictor... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:ThomasonMarga... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:SnowdenWendy... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:KendallLindsa... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:OdongoFlorenc... | lld:pubmed |
pubmed-article:21149918 | pubmed:author | pubmed-author:ARROW Trial... | lld:pubmed |
pubmed-article:21149918 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21149918 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:21149918 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21149918 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21149918 | pubmed:pagination | 1115-24 | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:meshHeading | pubmed-meshheading:21149918... | lld:pubmed |
pubmed-article:21149918 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:21149918 | pubmed:articleTitle | Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial. | lld:pubmed |
pubmed-article:21149918 | pubmed:affiliation | Joint Clinical Research Centre, Kampala, Uganda. | lld:pubmed |
pubmed-article:21149918 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21149918 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
pubmed-article:21149918 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:21149918 | pubmed:publicationType | Multicenter Study | lld:pubmed |